Insider Buyers Lose Additional US$63k As RAPT Therapeutics Dips To US$236m

The recent price decline of 73% in RAPT Therapeutics, Inc.'s ( NASDAQ:RAPT ) stock may have disappointed insiders who...

Related Keywords

Dirk Brockstedt , ,Insiders Are Selling The ,Scientific Officer Dirk Brockstedt ,Insider Transactions ,Nsider Ownership ,